Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Anti fibrin monoclonal antibody 3B6/22 Tc 99m

Drug Profile

Anti fibrin monoclonal antibody 3B6/22 Tc 99m

Alternative Names: Tc 99m 3B6/22; Tc 99m anti-fibrin monoclonal antibody 3B6/22; ThromboView

Latest Information Update: 16 Mar 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Agenix
  • Class Imaging agents; Monoclonal antibodies; Organotechnetium compounds; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds
  • Mechanism of Action Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Deep vein thrombosis; Pulmonary embolism

Highest Development Phases

  • Discontinued Deep vein thrombosis; Pulmonary embolism

Most Recent Events

  • 07 Dec 2015 Discontinued - Phase-I for Pulmonary embolism (Diagnosis) in Australia (IV)
  • 07 Dec 2015 Discontinued - Phase-II for Deep vein thrombosis (Diagnosis) in USA and Canada (IV)
  • 07 Dec 2015 Discontinued - Phase-II for Pulmonary embolism (Diagnosis) in USA and Canada (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top